1.8421
price up icon2.61%   0.0079
 
loading
Precedente Chiudi:
$1.85
Aprire:
$1.83
Volume 24 ore:
8,483
Relative Volume:
0.32
Capitalizzazione di mercato:
$10.03M
Reddito:
$2.35M
Utile/perdita netta:
$-2.56M
Rapporto P/E:
-4.1109
EPS:
-0.4481
Flusso di cassa netto:
-
1 W Prestazione:
+3.47%
1M Prestazione:
+7.19%
6M Prestazione:
-5.09%
1 anno Prestazione:
-21.56%
Intervallo 1D:
Value
$1.83
$1.89
Intervallo di 1 settimana:
Value
$1.81
$1.94
Portata 52W:
Value
$1.50
$2.87

Immuron Limited Adr Stock (IMRN) Company Profile

Name
Nome
Immuron Limited Adr
Name
Telefono
-
Name
Indirizzo
-
Name
Dipendente
7
Name
Cinguettio
@ImmuronLtd
Name
Prossima data di guadagno
2024-08-27
Name
Ultimi documenti SEC
Name
IMRN's Discussions on Twitter

Confronta IMRN con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
IMRN
Immuron Limited Adr
1.88 10.03M 2.35M -2.56M 0 -0.4481
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
441.62 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
521.55 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
325.10 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
560.88 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
243.05 28.51B 3.81B -644.79M -669.77M -6.24

Immuron Limited Adr Borsa (IMRN) Ultime notizie

pulisher
Jun 04, 2025

immuron ltd files for quotation of securities on ASX By Investing.com - Investing.com South Africa

Jun 04, 2025
pulisher
Jun 04, 2025

immuron ltd files for quotation of securities on ASX - Investing.com

Jun 04, 2025
pulisher
May 30, 2025

Immuron Letter to Shareholders: Projects Update - GlobeNewswire Inc.

May 30, 2025
pulisher
Mar 05, 2025

Immuron and Calmino join up to treat Irritable Bowel Syndrome (IBS) - Markets Insider

Mar 05, 2025
pulisher
Jan 30, 2025

Immuron: Targeted oral antibodies to treat infectious diseases - Innovation News Network

Jan 30, 2025
pulisher
Oct 04, 2024

NMRC Reports Results for Campylobacter Controlled Human Infection Model Study - GlobeNewswire

Oct 04, 2024
pulisher
Sep 05, 2024

Immuron: US FDA provides favourable feedback ahead of investigational new drug application for IMM-529 - Proactive financial news

Sep 05, 2024
pulisher
Jul 02, 2024

Immuron requests pre-IND meeting for IMM-529 with FDA filing - GlobeNewswire

Jul 02, 2024
pulisher
Apr 10, 2024

Why PriceSmart Shares Are Trading Higher By Around 5%; Here Are 20 Stocks Moving Premarket - Markets Insider

Apr 10, 2024
pulisher
Mar 07, 2024

U.S. shares higher at close of trade; Dow Jones Industrial Average up 0.34% - Investing.com UK

Mar 07, 2024
pulisher
May 16, 2023

Immuron Limited Announces Participation in the LD Micro Invitational XIII - The Kingston Whig-Standard

May 16, 2023
pulisher
Dec 01, 2022

Immuron Surges On U.S. DoD Funding For Travelan Research By Investing.com - Investing.com Nigeria

Dec 01, 2022
pulisher
Jul 26, 2022

Immuron US DoD Naval Medical Research Center Receives feedback on IND Application for New Campylobacter ETEC Therapeutic - StockTitan

Jul 26, 2022
pulisher
Jan 19, 2022

Immuron LimitedADR Shares Close the Week 61.5% HigherWeekly Wrap - Nasdaq

Jan 19, 2022
pulisher
Sep 10, 2020

IMRNImmuron Ltd Latest Stock News & Market Updates - Stock Titan

Sep 10, 2020
pulisher
Jun 27, 2018

Immuron Limited Trade Ideas — NASDAQ:IMRN - TradingView

Jun 27, 2018
pulisher
Jun 07, 2018

IMC Reports Rising Revenues & Eyes Colitis Market - Next Investors

Jun 07, 2018
pulisher
Jul 19, 2017

IMC Stock Price and Chart — ASX:IMC - TradingView

Jul 19, 2017

Immuron Limited Adr Azioni (IMRN) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$20.52
price up icon 0.32%
$35.83
price down icon 0.14%
$20.94
price up icon 1.31%
$101.15
price up icon 1.50%
$107.19
price up icon 0.30%
biotechnology ONC
$242.80
price up icon 1.05%
Capitalizzazione:     |  Volume (24 ore):